ORAL L‐DOPA TREATMENT OF PARKINSONISM
- 12 January 1970
- journal article
- clinical trial
- Published by Wiley in Acta Medica Scandinavica
- Vol. 187 (1-6), 247-255
- https://doi.org/10.1111/j.0954-6820.1970.tb02939.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- 5-hydroxyindoleacetic and homovanillic acid levels in the cerebrospinal fluid of healthy volunteers and patients with Parkinson's syndromeLife Sciences, 1967
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967
- Oxidative Conversion of 3-Methoxy-4-hydroxyphenyl (Vanyl) Compounds to Fluorescent Substances.Acta Chemica Scandinavica, 1967
- Some Observations on Adrenergic Connections between Mesencephalon and Cerebral HemispheresActa Pharmacologica et Toxicologica, 1964
- Demonstration and mapping out of nigro-neostriatal dopamine neuronsLife Sciences, 1964
- On the occurrence of homovanillic acid in brain and cerebrospinal fluid and its determination by a fluorometric methodLife Sciences, 1963
- DRUG‐INDUCED CHANGES IN THE CONCENTRATION OF 5‐OR INDOLYL COMPOUNDS IN CEREBROSPINAL FLUID AND CAUDATE NUCLEUSBritish Journal of Pharmacology and Chemotherapy, 1962
- A Fluorimetric Method for the Determination of Dopamine (3‐Hydroxytyramine.)Acta Physiologica Scandinavica, 1958
- A Method for the Fluorimetric Determination of Adrenaline and Noradrenaline in Tissues.1Acta Physiologica Scandinavica, 1958